ZA888931B - Novel rotavirus reassortant vaccine - Google Patents

Novel rotavirus reassortant vaccine

Info

Publication number
ZA888931B
ZA888931B ZA888931A ZA888931A ZA888931B ZA 888931 B ZA888931 B ZA 888931B ZA 888931 A ZA888931 A ZA 888931A ZA 888931 A ZA888931 A ZA 888931A ZA 888931 B ZA888931 B ZA 888931B
Authority
ZA
South Africa
Prior art keywords
novel
rotavirus
rotavirus reassortant
reassortant vaccine
novel rotavirus
Prior art date
Application number
ZA888931A
Other languages
English (en)
Inventor
Stanley A Plotkin
A Plotkin Stanley
H Fred Clark
Fred Clark H
Original Assignee
Wistar Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22425038&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA888931(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wistar Inst filed Critical Wistar Inst
Publication of ZA888931B publication Critical patent/ZA888931B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
ZA888931A 1987-11-30 1988-11-29 Novel rotavirus reassortant vaccine ZA888931B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12647787A 1987-11-30 1987-11-30

Publications (1)

Publication Number Publication Date
ZA888931B true ZA888931B (en) 1989-07-26

Family

ID=22425038

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA888931A ZA888931B (en) 1987-11-30 1988-11-29 Novel rotavirus reassortant vaccine

Country Status (12)

Country Link
EP (1) EP0323708B1 (de)
JP (1) JP2818760B2 (de)
AT (1) ATE128873T1 (de)
AU (1) AU618973B2 (de)
CA (1) CA1303525C (de)
DE (2) DE122006000071I1 (de)
ES (1) ES2079358T3 (de)
GR (1) GR3018262T3 (de)
IL (1) IL88534A (de)
LU (1) LU91297I2 (de)
NL (1) NL300252I2 (de)
ZA (1) ZA888931B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU618963B2 (en) * 1987-08-07 1992-01-16 Institut Pasteur Vaccines whose characteristic epitope is incorporated into a protein of picornavirus, in particular, poliovirus
US5626851A (en) * 1987-11-30 1997-05-06 The Wistar Institute Of Anatomy And Biology Rotavirus reassortant vaccine
WO1992001784A1 (en) * 1990-07-26 1992-02-06 The Wistar Institute Of Anatomy & Biology Rotavirus reassortant vaccine
US5610049A (en) * 1991-05-01 1997-03-11 The Wistar Institute Of Anatomy And Biology Human rotavirus HCR3A and method of growing said rotavirus
US5900238A (en) * 1995-07-27 1999-05-04 Immunex Corporation Vaccine delivery system
ID20581A (id) * 1996-10-18 1999-01-21 Res Fnd For Micbial Diseases O Antigen rotavirus, vaksin dan agen diagnostik untuk infeksi rotavirus, serta metode untuk menghasilkan antigen
CN110903403B (zh) * 2019-12-16 2021-07-13 中国农业大学 一种牛轮状病毒嵌合抗原以及检测牛轮状病毒抗体的胶体金免疫层析试纸卡
KR102374547B1 (ko) * 2021-05-31 2022-03-14 에스케이바이오사이언스(주) 재배열 로타바이러스의 제조 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4571385A (en) * 1983-06-27 1986-02-18 The United States Of America As Represented By The Department Of Health And Human Services Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors
US4636385A (en) * 1985-02-15 1987-01-13 The Wistar Institute Of Anatomy & Biology Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection

Also Published As

Publication number Publication date
ES2079358T3 (es) 1996-01-16
IL88534A (en) 1994-02-27
EP0323708B1 (de) 1995-10-11
IL88534A0 (en) 1993-12-08
GR3018262T3 (en) 1996-02-29
DE3854575T2 (de) 1996-05-15
EP0323708A1 (de) 1989-07-12
AU2630688A (en) 1989-06-01
JP2818760B2 (ja) 1998-10-30
LU91297I2 (fr) 2007-02-20
JPH02138970A (ja) 1990-05-28
DE3854575D1 (de) 1995-11-16
AU618973B2 (en) 1992-01-16
CA1303525C (en) 1992-06-16
ATE128873T1 (de) 1995-10-15
DE122006000071I1 (de) 2007-04-05
NL300252I1 (nl) 2007-01-01
NL300252I2 (nl) 2007-06-01

Similar Documents

Publication Publication Date Title
NL300252I1 (nl) Rotavirus-reassortanten-vaccin.
IL87608A0 (en) Recombinant dna-derived bordetella toxin subunit analogs
EP0192404A3 (de) Impfstoff, Verfahren zur Herstellung desselben und seine Anwendung für die Impfung von Menschen gegen eine Rotavirus-Infektion
PL351893A1 (en) Vaccines
GR3027744T3 (en) Human rotaviruses, vaccines and methods
PT939648E (pt) Formulações de vacinas de rotavírus
HU9701586D0 (en) Improved inactivated vaccines
EP0493575A4 (en) Rotavirus reassortant vaccine
Zapikian et al. Alternative approaches to the development of a rotavirus vaccine.
EP0402354A4 (en) Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine
EP0498804A4 (en) A method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms
EP0626008A4 (en) Vaccine containing acemannan as an adjuvant.
GB9709900D0 (en) Microencapsulated DNA for vaccination and gene therapy
EP0636030A4 (de) Impfstoff gegen das bacterientoxoid aus -i (pasteurellia haemolytica).
EP0293333A3 (en) A synthetic nonapeptide of use as an adjuvant
ZA888580B (en) New immunologically active synthetic peptides useful for preparing an antimalarial vaccine
Dodin et al. Shaba-Zaire choleric epidemy, 1983: Field-trial data on the activity of Institut Pasteur anticholeric oral vaccine.